OTCMKTS:AOXG Aoxing Pharmaceutical (AOXG) Stock Price, News & Analysis $0.0040 0.00 (0.00%) As of 06/18/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Aoxing Pharmaceutical Stock (OTCMKTS:AOXG) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aoxing Pharmaceutical alerts:Sign Up Key Stats Today's Range$0.0040▼$0.004050-Day Range N/A52-Week Range$0.0016▼$0.0107VolumeN/AAverage Volume2,426 shsMarket Capitalization$1.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Aoxing Pharmaceutical (OTCMKTS: AOXG) is a China-based company engaged in the research, development, manufacture and sale of active pharmaceutical ingredients (APIs), intermediates and finished dosage forms. The company’s product portfolio includes a variety of small-molecule APIs and botanical extracts designed to meet the needs of pharmaceutical, nutraceutical and cosmetic customers. Aoxing Pharmaceutical also offers custom synthesis and contract manufacturing services to support specialized client requirements. Headquartered in China, Aoxing Pharmaceutical operates manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards and other quality protocols. Its in-house R&D team focuses on process optimization, scale-up of new compounds and continuous improvement of production efficiencies. These capabilities enable the company to maintain tight quality control over its product lines and support ongoing pipeline development. Traded under the ticker AOXG on the OTC Markets, Aoxing Pharmaceutical serves domestic Chinese customers alongside select international partners in Asia and other regions. Its end markets include pharmaceutical manufacturers, healthcare providers and research institutions. The company continues to explore growth through expansion of its API offerings, enhancements in manufacturing technology and collaborations aimed at broadening its geographic footprint.AI Generated. May Contain Errors. Read More Receive AOXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aoxing Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AOXG Stock News HeadlinesTeva Pharmaceutical Industries Limited (TEVA)April 20, 2024 | finance.yahoo.comAoxing Pharmaceutical Company, Inc. (AOXG)January 23, 2024 | finance.yahoo.comBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to move out of overpriced AI stocks before the tech trade breaks down and into lesser-known names with real potential to challenge the Mag 7. One pick he calls 'an upgrade to Tesla stock' is a little-known company that just inked a partnership with Nvidia, positioning it ahead of Tesla in the autonomous vehicle race.June 20 at 1:00 AM | Chaikin Analytics (Ad)Aoxing Pharmaceutical Co Inc AOXGDecember 16, 2023 | morningstar.comMOPHLY Ono Pharmaceutical Co., Ltd.November 23, 2023 | seekingalpha.comAoxing Pharmaceutical Co (OTC:AOXG), Analyst Ratings, Price Targets, PredictionsJuly 12, 2022 | benzinga.comSee More Headlines AOXG Stock Analysis - Frequently Asked Questions How have AOXG shares performed this year? Aoxing Pharmaceutical's stock was trading at $0.0033 at the beginning of 2026. Since then, AOXG shares have increased by 21.2% and is now trading at $0.0040. How were Aoxing Pharmaceutical's earnings last quarter? Aoxing Pharmaceutical Company, Inc. (OTCMKTS:AOXG) posted its earnings results on Monday, May, 16th. The company reported $0.01 earnings per share (EPS) for the quarter. The business earned $6.56 million during the quarter. How do I buy shares of Aoxing Pharmaceutical? Shares of AOXG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aoxing Pharmaceutical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aoxing Pharmaceutical investors own include Agenus (AGEN), Chesapeake Energy (CHKAQ), Ballard Power Systems (BLDP), Company Calendar Last Earnings5/16/2016Today6/20/2026Fiscal Year End6/30/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED - DRUGS Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:AOXG Previous SymbolNYSEMKT:AXN CIKN/A Webaxzyen.icm.cn Phone(646) 367-1747Fax646-367-1747Employees350Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares381,210,000Free Float313,354,000Market Cap$1.52 million OptionableNot Optionable Beta7.48 The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (OTCMKTS:AOXG) was last updated on 6/20/2026 by MarketBeat.com Staff. From Our PartnersBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredHow to play the Biggest IPO in stock market history!SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insi...InvestPub | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredElon Is Quietly Doubling Down on This Bizarre AssetYahoo Finance reports this technology 'May Unlock $400 Trillion' - and Bloomberg calls it 'unavoidable.' Elon ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aoxing Pharmaceutical Company, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aoxing Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
